<SEC-DOCUMENT>0001193125-17-372253.txt : 20171218
<SEC-HEADER>0001193125-17-372253.hdr.sgml : 20171218
<ACCEPTANCE-DATETIME>20171218170833
ACCESSION NUMBER:		0001193125-17-372253
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20171218
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171218
DATE AS OF CHANGE:		20171218

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		171262126

	BUSINESS ADDRESS:	
		STREET 1:		ONE POST ST
		STREET 2:		MCKESSON PLAZA
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		4159838300

	MAIL ADDRESS:	
		STREET 1:		ONE POST ST
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d490920d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO SECTION 13 OR 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): December&nbsp;18, 2017 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>McKesson Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">1-13252</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">94-3207296</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>One Post Street,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>San Francisco, California</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>94104</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (415)
<FONT STYLE="white-space:nowrap">983-8300</FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former Name or Former Address, if Changed Since Last Report) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as
defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2&nbsp;of</FONT> the Securities Exchange Act of
<FONT STYLE="white-space:nowrap">1934&nbsp;(&#167;240.12b-2&nbsp;of</FONT> this chapter). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;18, 2017, McKesson Corporation (the &#147;Company&#148;) announced that it will appoint Britt&nbsp;Vitalone as its Executive Vice President
and Chief Financial Officer effective January&nbsp;1, 2018. Mr.&nbsp;Vitalone will replace James A. Beer who will be leaving the Company early next calendar year to become chief financial officer of Atlassian Corporation PLC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Vitalone, age 48, is currently Senior Vice President and Chief Financial Officer of U.S. Pharmaceutical and McKesson Specialty Health, which includes
responsibility for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> financial and accounting operations including long range planning and financial oversight of new strategic initiatives. From 2012 to
2014, Mr.&nbsp;Vitalone served as the Company&#146;s Senior Vice President, Corporate Financial Planning and Analysis and Mergers&nbsp;&amp; Acquisitions Finance with responsibility for the Company&#146;s financial planning, cash flow forecasting,
mergers an acquisitions and competitive analysis functions. From 2009 to 2012, he was Senior Vice President and Chief Financial Officer of the Company&#146;s Medical-Surgical business, having joined the Company in 2006 as Vice President, Finance of
the same business. Prior to joining the Company, Mr.&nbsp;Vitalone held a variety of financial leadership positions with General Electric Financial Assurance, CarMax, Inc. and Bausch&nbsp;&amp; Lomb Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Vitalone holds a Bachelor of Science degree in accounting from St. John Fisher College and is a certified public accountant. No family relationship
exists between Mr.&nbsp;Vitalone and any of the Company&#146;s directors or executive officers. Compensation for Mr.&nbsp;Vitalone associated with his new position has not been determined at the time of filing this report. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Regulation FD Disclosure. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;18, 2017, the Company issued a press release announcing that
Britt Vitalone will serve as the Company&#146;s new Executive Vice President and Chief Financial Officer following Mr.&nbsp;Beer&#146;s resignation effective December&nbsp;31, 2017. A copy of the Company&#146;s press release is attached hereto as
Exhibit 99.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in this item, including Exhibit 99.1, is furnished to the Securities and Exchange Commission (the
&#147;Commission&#148;), but shall not be deemed &#147;filed&#148; with the Commission for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d490920dex991.htm">Press release issued by the Company dated December&nbsp;18, 2017. </A></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: December 18, 2017 </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>McKesson Corporation</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Lori A. Schechter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Lori A. Schechter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Vice President, General Counsel and</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Compliance Officer</P></TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d490920dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g490920mckesson.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><B>McKESSON ANNOUNCES DEPARTURE OF JAMES BEER, EVP AND </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><B>CFO; APPOINTS INTERNAL SUCCESSOR, BRITT VITALONE; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><B>REAFFIRMS FISCAL 2018 OUTLOOK </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:ARIAL"><B>SAN
FRANCISCO, December&nbsp;18, 2017 &#150;</B> McKesson Corporation (NYSE:MCK) today announced James Beer, executive vice president and chief financial officer, will be leaving the company to pursue a new opportunity. Britt Vitalone, senior vice
president and chief financial officer, U.S. Pharmaceutical and McKesson Specialty Health, will be appointed executive vice president and chief financial officer of McKesson, effective January&nbsp;1, 2018.&nbsp;Beer will assist in a transition
period into early 2018. In addition, today the company reaffirmed its outlook of Adjusted Earnings of $11.80 to $12.50 per diluted share for the fiscal year ending March&nbsp;31, 2018. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:ARIAL">Beer has led the financial functions and been a member of the executive committee for McKesson since 2013. Under his leadership, the company has expanded
its retail presence, grown its specialty capabilities, enhanced its technology offerings, and created Change Healthcare, while navigating a rapidly evolving healthcare landscape. Beer will join Atlassian, an enterprise collaboration company, in San
Francisco, as chief financial officer, effective February 2018. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:ARIAL">&#147;James has been a wonderful colleague and friend. I admire his financial
discipline and management, and commitment to our company&#146;s shared values,&#148; says John Hammergren, chairman and chief executive officer, McKesson Corporation. &#147;We wish James well as he pursues his next opportunity.&#148;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:ARIAL">Vitalone has been with McKesson since 2006. Prior to his current role, Vitalone served as senior vice president, corporate financial planning and
analysis and M&amp;A finance, and senior vice president and chief financial officer, McKesson Medical-Surgical. Prior to McKesson, Vitalone held a variety of financial leadership positions with companies that include GE Financial Assurance, CarMax
and Bausch&nbsp;&amp; Lomb. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:ARIAL">Vitalone holds a Bachelor of Science degree in accounting from St. John Fisher College and is a certified
public accountant. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:ARIAL">&#147;For more than a decade, Britt has demonstrated an outstanding track record of performance in various finance and
operational roles across multiple businesses at McKesson. The board of directors, executive committee and I are excited to appoint Britt,&#148; commented Hammergren. &#147;We are confident that Britt&#146;s deep financial experience and knowledge
about our businesses will serve us well as we build upon McKesson&#146;s successes and position the company for future growth.&#148;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><B>Adjusted Earnings </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:ARIAL">McKesson separately reports financial results on the basis of Adjusted Earnings. Adjusted Earnings is a non-GAAP financial measure defined as GAAP income
from continuing operations, excluding amortization of acquisition-related intangible assets, acquisition-related expenses and adjustments, Last-In-First-Out (&#147;LIFO&#148;) inventory-related adjustments, gains from antitrust legal settlements,
restructuring charges, and other adjustments. McKesson&#146;s Adjusted Earnings outlook reflects current tax law and has not been adjusted for any potential tax law changes. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:ARIAL">McKesson presents non-GAAP diluted earnings per share from continuing operations on a forward-looking basis. The most directly comparable forward-looking
GAAP measure is diluted earnings per share from continuing operations. McKesson is unable to provide a quantitative reconciliation of this forward-looking non-GAAP measure to the most directly comparable forward-looking GAAP measure, without
unreasonable effort, because McKesson cannot reliably forecast LIFO inventory-related adjustments, gains from antitrust legal settlements, restructuring charges, and other adjustments, which are difficult to predict and estimate. These items are
inherently uncertain and depend on various factors, many of which are beyond our control. As such, any associated estimate and its impact on our GAAP performance could vary materially based on a variety of acceptable management assumptions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><B>Risk Factors </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:ARIAL">Except for historical information contained in this press release, matters discussed may constitute &#147;forward-looking statements&#148; within the
meaning of Section&nbsp;27A of the Securities Act of 1933 and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties that could cause actual results to differ materially from those projected,
anticipated or implied. These statements may be identified by their use of forward-looking terminology such as &#147;believes&#148;, &#147;expects&#148;, &#147;anticipates&#148;, &#147;may&#148;, &#147;will&#148;, &#147;should&#148;,
&#147;seeks&#148;, &#147;approximately&#148;, &#147;intends&#148;, &#147;plans&#148;, &#147;estimates&#148; or the negative of these words or other comparable terminology. The discussion of financial trends, strategy, plans or intentions may also
include forward-looking statements. It is not possible to predict or identify all such risks and uncertainties; however, the most significant of these risks and uncertainties are described in the company&#146;s Form 10-K, Form 10-Q and Form 8-K
reports filed with the Securities and Exchange Commission and include, but are not limited to: changes in the U.S. healthcare industry and regulatory environment; managing foreign expansion, including the related operating, economic, political and
regulatory risks; changes in the Canadian healthcare industry and regulatory environment; exposure to European economic conditions, including recent austerity measures taken by certain European governments; changes in the European regulatory
environment with respect to privacy and data protection regulations; fluctuations in foreign currency exchange rates; the company&#146;s ability to successfully identify, consummate, finance and integrate acquisitions; the company&#146;s ability to
manage and complete divestitures; material adverse resolution of pending legal proceedings; competition and industry consolidation; substantial defaults in payment or a material reduction in purchases by, or the loss of, a large customer or group
purchasing organization; the loss of government contracts as a result of compliance or funding challenges; public health issues in the U.S. or abroad; cyberattack, natural disaster, or malfunction of sophisticated internal computer systems to
perform as designed; the adequacy of insurance to cover property loss or liability claims; the company&#146;s failure to attract and retain customers for its software products and solutions due to integration and implementation challenges, or due to
an inability to keep pace with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">
technological advances; the company&#146;s proprietary products and services may not be adequately protected, and its products and solutions may be found to infringe on the rights of others;
system errors or failure of our technology products or services to conform to specifications; disaster or other event causing interruption of customer access to data residing in our service centers; the delay or extension of our sales or
implementation cycles for external software products; changes in circumstances that could impair our goodwill or intangible assets; new or revised tax legislation or challenges to our tax positions; general economic conditions, including changes in
the financial markets that may affect the availability and cost of credit to the company, its customers or suppliers; changes in accounting principles generally accepted in the United States of America; withdrawal from participation in multiemployer
pension plans or if such plans are reported to have underfunded liabilities; inability to realize the expected benefits from the company&#146;s restructuring and business process initiatives; difficulties with outsourcing and similar third party
relationships; risks associated with the company&#146;s retail expansion; and the company&#146;s inability to keep existing retail store locations or open new retail locations in desirable places. The reader should not place undue reliance on
forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements to
reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><B>About McKesson Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:ARIAL">McKesson Corporation, currently ranked 5<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> on the FORTUNE 500, is a global leader in healthcare
supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in
healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and
deliver opportunities that make our customers and partners more successful &#151; all for the better health of patients. McKesson has been named the &#147;<U>Most Admired Company</U>&#148; in the healthcare wholesaler category by FORTUNE, a
&#147;<U>Best Place to Work</U>&#148; by the Human Rights Campaign Foundation, and a top&nbsp;<U>military-friendly company</U>&nbsp;by Military Friendly. For more information, visit&nbsp;<U>www.mckesson.com</U>. </P>
<P STYLE="margin-top:11pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="center">### </P> <P STYLE="margin-top:11pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Contacts: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Craig Mercer, 415-983-8391 (Investors and Financial Media) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><U>Craig.Mercer@McKesson.com </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL">Kristin Hunter Chasen, 415-983-8974 (General and
Business Media) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><U>Kristin.Chasen@McKesson.com </U></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center">5 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g490920mckesson.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g490920mckesson.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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&*4=$?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
